Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Robert D who wrote (2616)	11/18/1997 6:54:00 PM
From: DR. BOND	Read Replies (1) \| Respond to of 23519

Robert.....You and I both know this stock is heading higher over the next few months. VVUS has never been a stock for weak hands to own. If you still believe in this co.'s growth prospects and have the $, 23 is very cheap. Good Luck, DB

To: Robert D who wrote (2616)	11/18/1997 7:02:00 PM
From: Zebra 365	Read Replies (2) \| Respond to of 23519

To All: 1) MUSE is a drug delivery system that is patented. Alprostadil is the drug delivered (in the current MUSE) and is generic. While others may use the drug, no one can deliver it with the same system, and VVUS has a lot of money now for lawyers if they try. 2) The problem with the stock is that we do not have a marketing affilation in the US with a Major player, i.e. Pfizer, Schering, but we have a major worldwide player Jannsen. However we have yet to have the production capacity or approval to sell overseas. The stock will not go anywhere until these two elements are in place, but this will be soon. As for ZONA, I was hoping for a pop after the SGP affiliation so I could short it. Now that the news is out I had to short it here, wanted it in the high 30's. ZONA is a one-product company that has to come from behind with an inferior drug and beat Pfizer. I'm still long VVUS. Everybody seems to think PFE is too expensive so it will probably go up, but I'm not trading it. Zebra